Name: Latest research reports of Dr. Lal Pathlabs Ltd. authored by Karvy and published by - Trendlyne research reports.
Item: Dr. Lal Pathlabs Ltd.
Rating: 3
Author: Karvy

Dr. Lal Pathlabs Ltd.

NSE: LALPATHLAB | BSE: 539524 | ISIN: INE600L01024 | Industry: Healthcare Services
| Mid-range Performer

2947.0000 -6.40 (-0.22%)

NSE Jun 16, 2025 15:31 PM

28.49% Gain from 52W Low

Volume: 84,875

Dr. Lal Pathlabs Ltd.

22 Aug 2019

2947.00

-0.22%

Dr. Lal PathLabs Ltd: Planned Expansions Boost Revenues

Hold: Dr. Lal Pathlabs Ltd.

Karvy

Dr Lal PathLabs (DLPL) Q1FY20 earnings came marginally higher than our estimates on account of improved revenue contribution from regions constituting

Dr. Lal Pathlabs Ltd. has an average target of 2992.60 from 5 brokers.